AACR Virtual Journal Club:
Molecular Cancer Research With Dr. Charles Chalfant
Moderated by: Adam Scheid, PhD
Molecular Cancer Research
Watch the recording of the AACR Journal Club session featuring Dr. Charles Chalfant discussing his article recently published in Molecular Cancer Research, "Ceramide Kinase Inhibition Drives Ferroptosis and Sensitivity to Cisplatin in Mutant KRAS Lung Cancer by Dysregulating VDAC-Mediated Mitochondria Function." This novel study depicts how CERK inhibition may serve as a new key point in a combination therapeutic strategy for NSCLC, specifically precision therapeutics targeting NSCLC possessing a KRAS mutation.
Stay tuned for the Q&A session at the end of the recording.
About the Featured Speaker:
Charles Chalfant, PhD, is a Professor of Medicine at the University of Virginia School of Medicine and a GS15 Senior Research Career Scientist at Richmond Veterans Administration Medical Center. He received his PhD from USF Health Morsani College of Medicine and was an F32 NIH Postdoctoral Fellow under Dr. Yusuf Hannun at Duke University Medical Center and the Medical University of South Carolina.